Characterization and Evaluation of a Novel Anticancer Drug, OSU-03012, As a Potential Therapeutic Agent for Hepatocellular Carcinoma
博士 === 國立臺灣大學 === 毒理學研究所 === 97 === Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death worldwide. The incidence of HCC is estimated to range from ranging 500,000 to 1,000,000 new cases annually, causing 600,000 deaths worldwide per year. Surger...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/38242575205064014360 |